| pubmed-article:10393047 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C0000981 | lld:lifeskim |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C0060520 | lld:lifeskim |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C0005529 | lld:lifeskim |
| pubmed-article:10393047 | lifeskim:mentions | umls-concept:C0004739 | lld:lifeskim |
| pubmed-article:10393047 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:10393047 | pubmed:dateCreated | 1999-7-8 | lld:pubmed |
| pubmed-article:10393047 | pubmed:abstractText | To investigate the effect of the carbonic anhydrase inhibitor acetazolamide (AZM) on passive permeability and active transport of fluorescein across the blood-retina barrier in healthy subjects. The study may have implications for the understanding of the edema-reducing effect of AZM. | lld:pubmed |
| pubmed-article:10393047 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10393047 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10393047 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10393047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10393047 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10393047 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10393047 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:10393047 | pubmed:issn | 0146-0404 | lld:pubmed |
| pubmed-article:10393047 | pubmed:author | pubmed-author:LarsenMM | lld:pubmed |
| pubmed-article:10393047 | pubmed:author | pubmed-author:Lund-Andersen... | lld:pubmed |
| pubmed-article:10393047 | pubmed:author | pubmed-author:SanderBB | lld:pubmed |
| pubmed-article:10393047 | pubmed:author | pubmed-author:MoldowBB | lld:pubmed |
| pubmed-article:10393047 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10393047 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:10393047 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10393047 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10393047 | pubmed:pagination | 1770-5 | lld:pubmed |
| pubmed-article:10393047 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:meshHeading | pubmed-meshheading:10393047... | lld:pubmed |
| pubmed-article:10393047 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10393047 | pubmed:articleTitle | Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. | lld:pubmed |
| pubmed-article:10393047 | pubmed:affiliation | Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark. | lld:pubmed |
| pubmed-article:10393047 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10393047 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10393047 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10393047 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10393047 | lld:pubmed |
